The U.S. Court of Appeals for the Third Circuit has jettisoned a nearly 30-year-old legal doctrine that often let companies defeat securities fraud claims by showing a swift rebound in their stock price. The ruling, issued September 30, effectively abrogates what the court called the Oran-Burlington rule, which had treated a stock's return to pre-disclosure levels as conclusive evidence that any alleged misstatements were immaterial. The decision vacates the dismissal of a shareholder class action against Ocugen, Inc., a small publicly traded pharmaceutical company, and its chief executive.
For companies and their advisors operating in federal courts in Pennsylvania, New Jersey, and Delaware, the shift is significant. Investors can no longer be barred from pursuing securities fraud claims solely because a stock price recovered within a few trading days. The ruling aligns the Third Circuit with the Supreme Court's 2011 decision in Matrixx Initiatives, Inc. v. Siracusano, which rejected categorical approaches to materiality in favor of a more holistic, fact-specific inquiry.
The underlying case illustrates the stakes. According to the amended complaint, a financial planning manager and a department head at Ocugen prepared a 20-page report flagging what they described as “manipulated numbers” being shared with the public. The company's chief financial officer allegedly told a colleague he had uncovered “multiple things that were wrong and the Company was misleading the public,” and that he had consulted a lawyer because he “learned something that isn't right.” When the Q2 2023 quarterly report came due, the CFO refused to sign it and was fired. The vice president of finance also refused and was also terminated. The chief executive then asked a financial reporting manager, appealing to “their shared Indian heritage,” according to the complaint. She refused as well, and the CEO signed the report himself.
In April 2024, Ocugen disclosed that it would restate 15 quarters of financial statements, admitting they were “materially misstated” and “should no longer be relied on.” The complaint alleged that the company had understated current liabilities by as much as 45.1% and overstated total stockholders' equity by as much as 18.6% in certain quarters. The day after the announcement, Ocugen's stock dropped 10.38%, from $1.54 to $1.38 per share, but recovered within two trading days. The district court treated that recovery as dispositive and dismissed the case.
The Third Circuit reversed. In a panel opinion, the court held that the Oran-Burlington rule could not survive the Supreme Court's 2011 decision, which rejected categorical approaches to materiality. The correct test, the court reaffirmed, is whether a false statement would have “significantly altered the total mix of information” available to reasonable investors at the time of their decisions. The court partially abrogated four of its own prior decisions and noted that no published Third Circuit opinion had applied the rule in 20 years.
The court affirmed dismissal on one narrow point: statements about the CFO's departure. The plaintiffs had not alleged a duty to disclose the specifics of that departure. On all other claims, the case returns to the district court for a fresh analysis of materiality and scienter.
This decision is part of a broader trend in federal courts to move away from bright-line rules in securities litigation. Advisors should note that similar categorical defenses may be less effective in the Third Circuit. For context, other recent enforcement actions, such as the SEC's $4.5M affinity fraud case and the federal fraud charges against Linqto's founder, underscore the regulatory focus on investor protection.
The ruling could have implications beyond Ocugen, potentially affecting pending and future securities class actions in the Third Circuit. Companies that have relied on quick stock recoveries to defeat claims may need to reassess their litigation strategies. For investors and their counsel, the decision removes a significant procedural hurdle, allowing cases to proceed to the merits.
